A Systematic Review on Mucormycosis in Corona Patients and its Treatment in India

  • S Rehan Ahmad Assistant Professor, Department of Zoology, HMM College for Women, Kolkata, India.
  • Pritha Ghosh Research Scholar, Raiganj University, Raiganj, West Bengal, India.
Keywords: Black Fungus, Mucormycosis, COVID-19, Comorbidity of Diabetes, Treatment of Black Fung


Several cases of mucormycosis infection are being reported from almost all states of India currently. Mucormycosis infection is rare but fatal. It is strongly associated with COVID- 19 as a secondary infection and increases the severity of COVID-19 infection. Fungi under Mucorales order are responsible for mucormycosis infection condition, especially people with a weak immune system and under steroid-based medication and antibiotic treatment are more vulnerable. COVID- 19 infected patients with associated risk factors like diabetes mellitus, neutropenia, diabetic ketoacidosis, organ transplant, cancer, AIDS, weak immunity, autoimmune disorders are more prone tosecondary opportunistic pathogenic infections. Special care and continuous monitoring process should be initiated as early as possible to prevent any kind of secondary fungal infections during COVID-19 infection. Though preventive strategies like antifungal therapy,and surgical debridement are present yetthemortality rate is very high in mucormycosis infection. Moreover, this current study is a brief summary of the current status, pathogenesis, management strategies, and latest guidelines for mucormycosis infection during the pandemic of coronavirusdisease 2019. Several treatment strategies like drugs, surgery, and other proper methods in hospital setups are also mentioned elaborately in this study. Appropriate doses, administration route and duration as well as reported cases of mucormycosis infection from different parts of India are also clearly documented here.

How to cite this article:
Ahmad SR, Ghosh P. A Systematic Review on Mucormycosis in Corona Patients and its Treatment in India. J Commun Dis. 2021;53(3):236-243.

DOI: https://doi.org/10.24321/0019.5138.202163


Athanasiadou KI, Athanasiadis DI, Constantinidis J, Anastasiou A, Roilides E, &Papakonstantinou E.

Successful treatment of rhinoorbitalmucormycosis due to Rhizopusarrhizus with liposomal amphotericin B,

posaconazole and surgical debridement in a child with neuroblastoma. Med Mycol Case Rep.2019;25:10-4.

[PubMed] [Google Scholar]

The Economic Times [Internet].Black fungus: How infection starts, death rate, treatment, medicine

& other key things to know; 2021. Accessed on 1st June, 2021. Available from: https://economictimes.



Brunet K, Rammaert B. Mucormycosis treatment: Recommendations, latest advances, and perspectives.

J Mycol Med. 2020;30(3):101007. [PubMed] [Google Scholar]

BusinessLine [Internet]. Govt restricts export of Amphotericin-B drug; 2021 Jun 1. Accessed on

th June, 2021. Available from: https://www.thehindubusinessline.com/news/national/


Cavassin FB, Baú-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of Amphotericin B: an overview

of the main antifungal agent used to treat invasive fungal infections. Infec Dis Ther. 2021;10(1):115-47.

[PubMed] [Google Scholar]

Centers for Disease Control and Prevention [Internet]. Where Mucormycosis Comes From; [cited

May 5]. Available from: https://www.cdc.gov/fungal/diseases/mucormycosis/causes.html

Centers for Disease Control and Prevention[Internet]. Mucormycosis;[cited 2021 May 5]. Available from: https://www.cdc.gov/fungal/diseases/mucormycosis/index.html

NORD [Internet].Mucormycosis;[cited 2021 May 5]. Available from: https://rarediseases.org/rare-diseases/


Centers for Disease Control and Prevention[Internet]. Symptoms of mucormycosis;[cited 2021 May 5].

Available from: https://www.cdc.gov/fungal/diseases/mucormycosis/symptoms.html

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SC, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE,

Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A,

Al-Hatmi AM, Arikan-AkdagliS, BadaliH, Ben-Ami R, BonifazA, Bretagne S, CastagnolaE, ChayakulkeereeM,

Colombo AL, Corzo-León DE, DrgonaL, GrollAH, Guinea J, HeusselCP, Ibrahim AS, KanjSS, KlimkoN,

LacknerM, LamothF, LanternierF, Lass-FloerlC, Lee DG, LehrnbecherT, LmimouniBE, Mares M, MaschmeyerG,

MeisJF, MeletiadisJ, Morrissey CO, NucciM, OladeleR, Pagano L, PasqualottoA, Patel A, RacilZ, Richardson M,

RoilidesE, RuhnkeM, SeyedmousaviS, SidharthanN, Singh N, SinkoJ, SkiadaA, SlavinM, SomanR, SpellbergB,

Steinbach W, Tan BH, UllmannAJ, VehreschildJJ, VehreschildMJ, Walsh TJ, White PL, WiederholdNP,

ZaoutisT, ChakrabartiA;Mucormycosis ECMM MSG Global Guideline Writing Group. Global guideline for

the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical

Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect

Dis.2019;19(12):e405-e421. [PubMed] [Google Scholar]

The Weather Channel[Internet]. COVID-19 India FAQs:What is Black Fungus, How It Spreads, Who It Can

Infect and More. Accessed on 5th June, 2021. Available from: https://weather.com/en-IN/india/coronavirus/


Deccan Herald [Internet]. Covid-19 crisis: Whichstates in India have reported the highest number of

mucormycosis cases?;2021 May 22. Accessed on 2nd June, 2021. Available from: https://www.deccanherald.



Ervens J, Ghannoum M, Graf B, Schwartz S. Successful isavuconazole salvage therapy in a patient with invasive mucormycosis. Infection.2014;42(2):429-32. [PubMed] [Google Scholar]

Gebremariam T, Wiederhold NP, Alqarihi A, Uppuluri P, Azie N, Edwards JE, Ibrahim AS. Monotherapy

or combination therapy of isavuconazole and micafungin for treating murine mucormycosis. J

AntimicrobChemother. 2017;72(2):462-6. [PubMed] [Google Scholar]

The Directorate General of Health Services, Ministry of Health & Family Welfare[Internet]. Guideline

for management of Mucormycosis in Covid – 19 patients; 2021. Accessed on 5th June, 2021. Available

from: https://dghs.gov.in/WriteReadData/News/202105171119301555988MucormycosismanagementinCovid-


Hernández JL, Buckley CJ. Mucormycosis.StatPearls; 2021. [PubMed] [Google Scholar]

Ibrahim AS, Avanessian V, Spellberg B, Edwards JE. Liposomal Amphotericin B, and not Amphotericin B

Deoxycholate, improves survival of diabetic mice infected with Rhizopusoryzae. Antimicrob Agents Chemother.

;47(10):3343-4. [PubMed] [Google Scholar]

Ibrahim AS, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE, Spellberg B. Comparison of Lipid Amphotericin B preparations in treating murine zygomycosis. Antimicrob Agents Chemother.2008;52(4):1573-6.

[PubMed] [Google Scholar]

Kapur M [Internet]. Why does India have so many cases of post-Covidmucormycosis?Quartz; 2021 May

Accessed on 1st June, 2021. Available from: https://qz.com/india/2012257/why-india-has-so-many-casesof-


Luo G, Gebremariam T, Lee H, Edwards JE, Kovanda L, Ibrahim AS. Isavuconazoletherapy protects immunosuppressed mice from mucormycosis. Antimicrob Agents Chemother.2014;58(4):2450-3. [PubMed] [Google Scholar]

Luo G, Gebremariam T, Lee H, French SW, Wiederhold NP, Patterson TF, Filler SG, Ibrahim AS. Efficacy

of Liposomal Amphotericin B and Posaconazole in intratrachealmodels of murine mucormycosis. Antimicrob

Agents Chemother.2013;57(7):3340-7. [PubMed] [Google Scholar]

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane

KM, Perfect JR, Thompson GR, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N,

Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, VehreschildJJ,

Young JA, ChetchotisakdP, JaruratanasirikulS, KanjSS, EngelhardtM, KaufholdA, Ito M, Lee M, Sasse C, Maher

RM, ZeiherB, VehreschildMJ; VITAL and FungiScopeMucormycosis Investigators. Isavuconazole treatment

for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis.2016;16(7):828-

[PubMed] [Google Scholar]

Mascarenhas A [Internet]. Explained: What is mucormycosis or ‘black fungus’ in Covid-19 patients, its

symptoms and treatment. The Indian Express; 2021 Jun 8. Accessed on 8th June, 2021Available from: https://


Mathur A [Internet]. Amphotericin B not only medication available for black fungus: ICMR tells Delhi HC. India

Today; 2021 Jun 4. Accessed on 7th June, 2021. Available from: https://www.indiatoday.in/coronavirus-outbreak/


Mehta S, Pandey A. Rhino-Orbitalmucormycosisassociated with COVID-19. Cureus. 2020 Sep;12(9):e10726.

[PubMed] [Google Scholar]

EshkaletiMN, KordbachehP, HashemiSJ, FalahatiM, ZainiF, MirhendiH, SafaraM, HosseinpoorL. In vitro

activity of Amphotericin B in combination with statins against clinical and environmental Rhizopusoryzae

Strains. Iran J Public Health.2019 May;48(5):943-8. [PubMed] [Google Scholar]

Natesan SK, Chandrasekar PH. Isavuconazole for the treatment of invasive aspergillosis and mucormycosis:

current evidence, safety, efficacy, and clinical recommendations. Infect Drug Resist. 2016;9:291-300.

[PubMed] [Google Scholar]

News18 [Internet]. Black Fungus Kills 8 Covid-Recovered Patients in Maharashtra; Gujarat Too Reports Cases;

May 8. Accessed on 5th June, 2021. Available from: https://www.news18.com/news/india/black-fungus-8-


LiveMint [Internet]. Black fungus detected in Covid-19 patients, not ‘big outbreak’, says NitiAayog;2021 May

Accessed on 5th June, 2021. Available from: https://www.livemint.com/news/india/black-fungus-detected-


Noor A, Preuss CV. Amphotericin B.StatPearls;2021. [PubMed] [Google Scholar]

Priya P, Ganesan V, Rajendran T, Geni VG. Mucormycosis in a tertiary care centerin South India: A 4-year

experience. Indian J Crit Care Med.2020;24(3):168-71. [PubMed] [Google Scholar]

The Print [Internet]. At least 8 Covid survivors die of black fungus ‘mucormycosis’ in Maharashtra. Accessed

on 2nd June, 2021. Available from: https://theprint.in/health/at-least-8-covid-survivors-die-of-black-fungusmucormycosis-in-maharashtra/654924/

Rai S, Yadav S, Kumar D, Kumar V, Rattan V. Management of rhinomaxillarymucormycosis with Posaconazole

in immunocompetent patients. J Oral BiolCraniofac Res.2016;6. [PubMed] [Google Scholar]

Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for

India amidst the second wave? Lancet Respir Med. 2021;9(8):e77.[PubMed] [Google Scholar]

Salas V, Pastor FJ, Calvo E, Alvarez E, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J. In Vitroand in

vivo activities of Posaconazole and Amphotericin B in a murine invasive infection by mucorcircinelloides: poor

efficacy of Posaconazole. Antimicrob Agents Chemother. 2012;56(5):2246-50. [PubMed] [Google Scholar]

ICMR [Internet].Evidence based advisory in the time of COVID-19: screening, diagnosis &management of

mucormycosis; [cited 2021 Jun 8]. Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_


India Infoline [Internet]. DCGI approves 5 more pharma companies to produce Amphotericin B injection in India. Accessed on 5th June, 2021. Available from: https://www.indiainfoline.com/article/news-top-story/dcgi-approves-5-more-pharma-companies-to-produce-amphotericin-b-injection-in-india-121052100211_1.html

Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly

addition to the pandemic spectrum. J Laryngol Otol.2021;135(5):442-7. [PubMed] [Google Scholar]

Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP. Therapy of Mucormycosis. J Fungi.

;4(3):90. [PubMed] [Google Scholar]

Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL; European

Conference on Infections in Leukemia. Diagnosis and treatment of mucormycosis in patients with hematological

malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica.

;98(4):492-504. [PubMed] [Google Scholar]

Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. The

Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded,

placebo-controlled trial. J AntimicrobChemother. 2012;67(3):715-22. [PubMed] [Google Scholar]

NDTV [Internet]. Gujarat hospital reports rise in Covidcases with black fungus infection. Accessed on 2nd

June, 2021. Available from: https://www.ndtv.com/india-news/coronavirus-black-fungal-infection-gujarat-


The Economic Times [Internet]. Maharashtra to get 60,000 vials of drug for mucormycosis from June 1

through global tender: Rajesh Tope. Accessed on 29th May, 2021. Available from: https://economictimes.indiatimes.com/news/india/maharashtra-to-get-60000-vials-of-drug-for-mucormycosis-from-june-1-throughglobal-tender-rajesh-tope/articleshow/82940289.cms?from=mdr

Times Now News [Internet]. Mucormycosis, black fungus, raises its head in Delhi hospital: All you need to

know about this fatal infection. Accessed on 29th May, 2021. Available from: https://www.timesnownews.



LiveMint [Internet].As black fungus cases rise in India, AIIMS chief lists key factors to prevent mucormycosis;

May 21. Accessed on 2nd June, 2021. Available from: https://www.livemint.com/news/india/as-mucormycosis-cases-rise-in-india-aiims-director-lists-keyfactors-to-prevent-black-fungus-11621592318715.html

Rema Nagarajan / TNN / Updated: May 30, 2021. Covid-19: Shortage of black fungus drug Amphotericin-B

looming: India News - Times of India. Accessed on 28th May , 2021The Times of India. https://timesofindia.